PubMed COVID-19 Clinical Care
1391 - 1400 of 3573 results found
Erratum: Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients: Erratum
Description
[This corrects the article DOI: 10.1097/HM9.0000000000000030.].
Experiences of university teachers with rotational blended learning during the COVID-19 pandemic: A qualitative case study
Description
This qualitative case study examines the self-efficacy of university teachers during the COVID-19 pandemic as they struggle to incorporate new technology, teaching strategies, and curriculum delivery in the shift from total remote learning to
Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts
Description
BACKGROUND: Although COVID-19 vaccines and their booster regimens protect against symptomatic infections and severe outcomes, there is limited evidence about their protection against asymptomatic and symptomatic infections in real-world settings
Effect of antihypertensive agents on the clinical outcome of hospitalized COVID-19 patients concomitant with hypertension: A systematic review and meta-analysis
Description
CONCLUSION: nder the current circumstance of the sustained COVID-19 pandemic, it is recommended to continue the use of antihypertensive agents for patients with hypertension during COVID-19 infection, as it can help reduce the risk of mortality.
Examining Excess Mortality Among Critical Workers in Minnesota During 2020-2021: An Occupational Analysis
Description
Objectives. To understand the occupational risk associated with COVID-19 among civilian critical workers (aged 16-65 years) in Minnesota. Methods. We estimated excess mortality in 2020 to 2021 for critical occupations in different racial groups and
e-Consent in UK academic-led clinical trials: current practice, challenges and the need for more evidence
Description
CONCLUSION: e-Consent is increasingly used in academic-led trials, yet uncertainties remain amongst trialists, patients and members of the public. Uncertainties include a lack of formal, practical guidance and a lack of evidence to demonstrate
Effect of Immunosuppressive or Immunomodulatory Agents on Severe COVID-19 Outcomes: A Population-Based Cohort Study
Description
CONCLUSION: Current use of MMF and glucocorticoids were associated with an increased risk of severe COVID-19 outcomes compared with nonuse. These results emphasize the variety of circumstances of patients taking IIAs.
Editorial: The immunological role of platelet activation in the pathophysiology of COVID-19
Description
No abstract
